[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334873-105":59,"doc-detail-334873-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","exploring-the-dna-methylation-profile-of-genes-associated-with-bladder-cancer-in-bladder-tissue-of-patients-with-neurogenic-lower-urinary-tract-dysfunction-read-paper","Exploring the DNA Methylation Profile of Genes Associated with Bladder Cancer in Bladder Tissue of Patients with Neurogenic Lower Urinary Tract Dysfunction - read paper","","DNA methylation is an epigenetic process that often occurs in gene promoters and leads to transcriptional silencing, and it is frequently observed in bladder cancer, influencing tumor initiation and progression. Bladder cancer is a major concern in neurogenic lower urinary tract dysfunction (NLUTD), yet disease mechanisms remain unclear. A prospective study of NLUTD patients used cystoscopy with biopsy and quantitative methylation-specific PCR to assess promoter methylation of RASSF1, RARβ, DAPK, hTERT, and APC genes in bladder tissue. Hypermethylation occurred in at least one gene in all samples: RAR-β 91.7%, RASSF1 and DAPK 83.3%, APC 37.5%, and none for TERT. Recurrent UTIs correlated with the number of hypermethylated genes, while other clinical characteristics showed no significant association, suggesting an epigenetic field effect and possible cancer risk.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-dna-methylation-profile-of-genes-associated-with-bladder-cancer-in-bladder-tissue-of-patients-with-neurogenic-lower-urinary-tract-dysfunction-read-paper/334873/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-dna-methylation-profile-of-genes-associated-with-bladder-cancer-in-bladder-tissue-of-patients-with-neurogenic-lower-urinary-tract-dysfunction-read-paper/334873.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main biological mechanism studied in this paper?","Question",{"text":112,"@type":113},"The paper focuses on DNA methylation, an epigenetic modification occurring in gene promoters that can silence gene transcription.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes were analyzed for promoter methylation in bladder tissue?",{"text":117,"@type":113},"RASSF1, RARβ, DAPK, hTERT, and APC promoter methylation were assessed using quantitative methylation-specific PCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between recurrent UTIs and methylation?",{"text":121,"@type":113},"The number of hypermethylated genes was significantly associated with recurrent UTIs (p = 0.0048).",{"name":123,"@type":110,"acceptedAnswer":124},"What were the most common histopathological findings among the patients?",{"text":125,"@type":113},"Histopathology was normal in 8.3% of patients, chronic inflammation appeared in 83.3%, and squamous cell metaplasia was found in 16.7%.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},334873,1790012962,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":4},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Article  \nExploring the DNA Methylation Profile of Genes Associated with Bladder Cancer in Bladder Tissue of Patients with Neurogenic Lower Urinary Tract Dysfunction  \nPeriklis Koukourikis 1, Maria Papaioannou 2, Stavroula Pervana 3 and Apostolos Apostolidis 1, *  \nCitation: Koukourikis, P.;  \nPapaioannou, M.; Pervana, S.; Apostolidis, A. Exploring the DNA Methylation Profile of Genes Associated with Bladder Cancer in Bladder Tissue of Patients with Neurogenic Lower Urinary Tract Dysfunction. Int. J. Mol. Sci. 2024, 25, 5660. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25115660  \nAcademic Editor: Yasemin M. Akay  \nReceived: 31 March 2024  \nRevised: 12 May 2024  \nAccepted: 19 May 2024  \nPublished: 23 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 2nd Department of Urology, Aristotle University of Thessaloniki, General Hospital ‘Papageorgiou’,  \n56403 Thessaloniki, Greece; [periskouk@gmail.com](periskouk@gmail.com)  \n2 Department of Biological Chemistry, Medical School, Aristotle University of Thessaloniki,  \n54124 Thessaloniki, Greece; [mpapaioannou@auth.gr](mpapaioannou@auth.gr)  \n3 Department of Pathology, General Hospital ‘Papageorgiou’, 56403 Thessaloniki, Greece; [st.pervana@gmail.com](st.pervana@gmail.com)  \n* Correspondence: [apoapo@auth.gr](apoapo@auth.gr)  \nAbstract: DNA methylation is an epigenetic process that commonly occurs in genes’ promoters and results in the transcriptional silencing of genes. DNA methylation is a frequent event in bladder cancer, participating in tumor initiation and progression. Bladder cancer is a major health issue in patients suffering from neurogenic lower urinary tract dysfunction (NLUTD), although the pathogenetic mechanisms of the disease remain unclear. In this population, bladder cancer is characterized by aggressive histopathology, advanced stage during diagnosis, and high mortality rates. To assess the DNA methylation profiles of five genes’ promoters previously known to be associated with bladder cancer in bladder tissue of NLUTD patients, we conducted a prospective study recruiting NLUTD patients from the neuro-urology unit of a public teaching hospital. Cystoscopy combined with biopsy for bladder cancer screening was performed in all patients following written informed consent being obtained. Quantitative methylation-specific PCR was used to determine the methylation status of RASSF1, RARβ, DAPK, hTERT, and APC genes’ promoters in bladder tissue samples. Twenty-four patients suffering from mixed NLUTD etiology for a median duration of 10 (IQR: 12) years were recruited in this study. DNA hypermethylation was detected in at least one gene of the panel in all tissue samples. RAR-β was hypermethylated in 91.7% samples, RASSF and DAPK were hypermethylated in 83.3% samples, APC 37.5% samples, and TERT in none of the tissue samples. In 45.8% of the samples, three genes of the panel were hypermethylated, in 29.2% four genes were hypermethylated, and in 16.7% and in 8.3% of the samples, two and one gene were hypermethylated, respectively. The number of hypermethylated genes of the panel was significantly associated with recurrent UTIs (p = 0.0048) . No other significant association was found between DNA hypermethylation or the number of hypermethylated genes and the clinical characteristics of the patients. Histopathological findings were normal in 8.3% of patients, while chronic inflammation was found in 83.3% of patients and squamous cell metaplasia in 16.7% of patients. In this study, we observed high rates of DNA hypermethylation of genes associated with bladder cancer in NLUTD patients, suggesting an epigenetic field effec","cbCaiareoudfaSDk","https://ap.wps.com/l/cbCaiareoudfaSDk","pdf",462402,11,"English","# Abstract\n## Methods\n## Key findings\n## Associations and clinical correlations\n# Introduction","[{\"question\":\"What is the main biological mechanism studied in this paper?\",\"answer\":\"The paper focuses on DNA methylation, an epigenetic modification occurring in gene promoters that can silence gene transcription.\"},{\"question\":\"Which genes were analyzed for promoter methylation in bladder tissue?\",\"answer\":\"RASSF1, RARβ, DAPK, hTERT, and APC promoter methylation were assessed using quantitative methylation-specific PCR.\"},{\"question\":\"What relationship did the study find between recurrent UTIs and methylation?\",\"answer\":\"The number of hypermethylated genes was significantly associated with recurrent UTIs (p = 0.0048).\"},{\"question\":\"What were the most common histopathological findings among the patients?\",\"answer\":\"Histopathology was normal in 8.3% of patients, chronic inflammation appeared in 83.3%, and squamous cell metaplasia was found in 16.7%.\"}]","Exploring the DNA Methylation Profile of Genes Associated with Bladder Cancer in Bladder Tissue of Patients with Neurogenic Lower Urinary Tract Dysfunction - read paper | PDF",1790008704,28]